The use of sensitivity encoding and a gradient echo sequence in dynamic susceptibility contrast (DSC) perfusion imaging at 3T leads to fewer artifacts and better diagnostic quality, according to award-winning research from Denmark.
The use of sensitivity encoding and a gradient echo sequence in dynamic susceptibility contrast (DSC) perfusion imaging at 3T leads to fewer artifacts and better diagnostic quality, according to award-winning research from Denmark.
DSC perfusion examinations at 3T are associated with pronounced artifacts close to tissue/bone and tissue/air interfaces, which mean that parts of the brain cannot be evaluated properly. Clinicians and researchers are reluctant to use this technique in conditions where these areas play an important role, such as Alzheimer's disease, stroke, epilepsy, and brain tumor.
To optimize DSC imaging at 3T, Anne Dorte Blankholm, a radiographer at the MR Centre in Aarhus University Hospital, Skejby, performed examinations on 12 healthy volunteers using a GE Signa HD machine. She presented details about her study in a special exhibition at the ISMRM-ESMRMB meeting organized by the Society of MR Technologists.
Six of the volunteers had a standard gradient echo (GRE) echo-planar imaging (EPI) perfusion sequence and a GRE EPI perfusion sequence during which the parallel imaging technique sensitivity encoding (SENSE/ASSET) was used. The other six had a GRE EPI perfusion examination and a spin echo (SE) EPI sequence.
An injection of Gadovist (gadobutrol, 604.72 mg/ml, 1 mmol/ml, Schering) was given in an antecubital vein. The first group of volunteers had an injection of 0.1 mmol/kg of body weight for each of the GRE sequences. The second group had 0.1 mmol/kg of body weight for the GRE sequence and 0.2 mmol/kg of body weight for the SE sequence.
The size of susceptibility artifacts was evaluated by measuring the area of visible brain for each sequence. On a GE Advanced Windows workstation, readers indicated by hand the area of visible brain, not including the susceptibility artifacts, on each slice in the series. The two-tailed t-test for matched pairs was used for statistical analysis. To assess the impact of the sequences on perfusion data, the signal-to-noise ratio was calculated in a region of interest containing both grey and white matter.
The diagnostic quality was evaluated by an experienced neuroradiologist, who rated the perfusion maps and the perfusion modulus images.
"The results showed that SENSE technology reduces susceptibility artifacts in DSC imaging at 3T," Blankholm noted. "Use of SENSE on the GRE perfusion sequence minimized susceptibility artifacts. The SNR and diagnostic quality increased when SENSE was used."
The results comparing the GRE and SE sequences showed that the SE displayed fewer susceptibility artifacts. There was no significant difference in SNR at baseline, and significant differences were found for SNR peak contrast where the GRE sequence displayed the best signal, according to Blankholm.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 5th 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 5th 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 5th 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.